| 000 | 01029 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250515065248.0 | ||
| 264 | 0 | _c20070504 | |
| 008 | 200705s 0 0 eng d | ||
| 022 | _a1538-3598 | ||
| 024 | 7 |
_a10.1001/jama.297.17.1917 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPsaty, Bruce M | |
| 245 | 0 | 0 |
_aFDA responds to institute of medicine drug safety recommendations--in part. _h[electronic resource] |
| 260 |
_bJAMA _cMay 2007 |
||
| 300 |
_a1917-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAdverse Drug Reaction Reporting Systems |
| 650 | 0 | 4 | _aDrug Approval |
| 650 | 0 | 4 | _aNational Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 700 | 1 | _aCharo, R Alta | |
| 773 | 0 |
_tJAMA _gvol. 297 _gno. 17 _gp. 1917-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/jama.297.17.1917 _zAvailable from publisher's website |
| 999 |
_c17021158 _d17021158 |
||